Eldepryl Capsules Dosage
Generic name: SELEGILINE HYDROCHLORIDE 5mg
Dosage form: capsule
Medically reviewed on June 26, 2018.
ELDEPRYL is intended for administration to Parkinsonian patients receiving levodopa/carbidopa therapy who demonstrate a deteriorating response to this treatment. The recommended regimen for the administration of ELDEPRYL is 10 mg per day administered as divided doses of 5 mg each taken at breakfast and lunch. There is no evidence that additional benefit will be obtained from the administration of higher doses. Moreover, higher doses should ordinarily be avoided because of the increased risk of side effects.
After two to three days of selegiline treatment, an attempt may be made to reduce the dose of levodopa/carbidopa. A reduction of 10 to 30% was achieved with the typical participant in the domestic placebo controlled trials who was assigned to selegiline treatment. Further reductions of levodopa/carbidopa may be possible during continued selegiline therapy.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Eldepryl (selegiline)
- Eldepryl Side Effects
- During Pregnancy or Breastfeeding
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 1 Review
- Generic Availability
- Drug class: dopaminergic antiparkinsonism agents